Posted Sep. 27, 2012 at 2:37 p.m.

Premium Lock GSK, drug firms pay U.S. $6.6B in 2012 to settle fraud cases

Published: 2012-09-27 14:37:00
Updated: 2012-09-27 14:37:00

Print this blog post
Healthcare reform Healthcare reform

Fines and penalties rose from $2.5 billion in 2011, aided by a record $3 billion settlement by Glaxo in July, Public Citizen said in a report Thursday. Common frauds include overcharging government programs such as Medicare and pushing doctors to prescribe drugs for unapproved uses....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 Bloomberg. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Scroll